Moderna, Inc. — Director's Dealing 2025

Aug 6, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Moderna, Inc. (MRNA)
CIK: 0001682852
Period of Report: 2025-08-05

Reporting Person: Rubenstein David M. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-08-05	Common Stock	M	850	—	Acquired	1527	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-08-05	Restricted Stock Units	$	M	850	Disposed		Common Stock (850)	Direct

Footnotes

F1: Restricted stock units convert into common stock on a one-for-one basis.

F2: The shares subject to this restricted stock unit award vested in full on August 5, 2025.